Compelling @Newsweek article by @KristinHugo re: safety w/ egg donation. @AlanPenzias of @BostonIVF is quoted. t.co/Cb7AAnXk3m
We are happy to do so! Glad it worked out so well. t.co/7cJSvJSkBa
Maggie won last year, so she understands! t.co/1ut5IeqiwF
Team @OvaScience had a great time at @RESOLVENewEng #NEWoH yesterday. Thanks to all employees, friends & family (pe… t.co/PiUYmFuCEA
OvaScience makes miracles happen. Founded in 2011, with the goal of improving the treatment of infertility, the company assembled a team of scientists, physicians and advisers that are recognized leaders in the field of reproductive medicine. In 2015, baby Zain Rajani was born. Zain was the first baby born with the assistance of OvaScience's first product (AUGMENT) which increases the success of in vitro fertilization (IVF) and uses the mothers own cellular energy to revitalize her egg. For Bessemer, backing the OvaScience founders in 2011 was an easy decision. We’d funded Michelle Dipp, Christoph Westphal, and Rich Aldrich before. (In fact, we’ve funded Christoph five times!) OvaScience (NASDAQ: OVAS) became a public company in 2012.